What is "Nanotis"?

All you need is Nanotis with your smartphone

Solve various problems in infectious disease tests such as influenza

Just with a Micro-chip and your Smartphone

Wherever

Whoever

Whenever

Our Teams

CEO, Founder | Lisa Sakashita

M. S. degree from department of Physics, the University of Tokyo. B. S. degree from department of Physics, Tokyo University of Science. Her career includes: Nomura Securities, Co., Ltd. (analyst, Investment Banking division.), Bloomberg LLP (data analyst), Ginza Galleries (International Public Relations/Overseas Project Integration) and Linkers Corporation (Managing Executive Officer). At Linkers Corporation, a start-up company in the technology matching service industry, she won MVP for top sales.

CTO, Founder | Michika Onoda

B. S. and M. S. degree from faculty of Materials Engineering, the University of Tokyo (Top Graduate, Dean’s Award). He is currently attending the Ph. D. course at Yoshida lab, faculty of Materials Engineering, Department of Engineering, the University of Tokyo.
Under the supervision of Prof. Yoshida, he is engaged in research on functional polymers, biomaterials, biomimetics, and non-linear non-equilibrium chemistry.
He was awarded the University of Tokyo President’s Award on his research about artificial amoeba utilizing polymeric fluids. In his career, he won more than ten awards at domestic and international conferences including Royal Society of Chemistry Soft Matter Award.
In addition to his research, he established science media and works as a writer collaborating with

Technology Director | Akihiro Eguchi

B. S. degree from faculty of Chemistry and Biotechnology Engineering, the University of Tokyo. He is currently attending the master course at Nagamune lab., faculty of Chemistry and Biotechnology Engineering, Department of Engineering, the University of Tokyo.
Under the supervision of Prof. Nagamune, he is engaged in research on biotechnology such as cell and protein engineering, and developing a system to detect protein-protein interaction utilizing a cell fate and signaling. In this work, he was awarded Best Oral Presentation Award at The 29th Annual and International Meeting of the Japanese Association for Animal Cell Technology (JAACT 2016).

Technology Director | Yoko Nagai

As an engineer, Nagai has been engaged in general equipment analyses and drug R&D in the field of biochemistry for 12 years at major pharmaceutical companies and a food manufacturer, etc. After graduating from university, she joined a national project team of Keio University. Then, she was engaged in R&D of injectables for hepatitis C and osteoporosis at a major domestic pharmaceutical company, and assessment of adverse drug reaction cases at a foreign pharmaceutical company.
Nagai joined Nanotis due to her deep affinity with our mission concept of “Whenever, Wherever, and Whoever.”

Member of the Board | Koji Nakao

Corporate adviser of Terumo Corporation, Chairman of The Japan Federation of Medical Devices Associations, Chairman of Medical Technology Association of Japan, Director of The Japan Association for Medtech Innovation

B. L. degree from the Faculty of Law, Keio University. Nakao started his career at Terumo Corporation in 1970. Then he successively assumed the posts of Chairman & CEO of Terumo Medical Corporation (US), and Director, Vice President, and Executive Officer at Terumo Corporation. He was then elected as Chairman of the Board of the company in 2011. Since 2016, he has been the Corporate Adviser of Terumo Corporation.

Technical Advisor | Teruyuki Nagamune, Ph. D.

B. S., M. S., and Ph. D. degree from school of Chemical Engineering, Tokyo Institute of Technology in 1973, 1975, and 1985. His career includes: RIKEN (Research Scientist from 1977), University of Illinois (Visiting Researcher from 1988), RIKEN (Vice Senior Research Scientist from 1992), the University of Tokyo (Professor from 1993). Dr. Nagamune is the winner of the 25th Ichimura Award (1993), The SCEJ Award (Tamaki Medal) (2002), Ichimura Prize, IUPAC Fellow on Biotechnology, The SCEJ Award (Ikeda Medal) (2014), etc.

Collaborator | M. Kawahara lab., the Univ. of Tokyo

The target of the research group is to invent applications in the field of medical engineering by applying gene engineering, protein engineering, enzyme engineering, etc to biomolecules such as cells or proteins.

Collaborator | Norio Omagari M.D., M.Sc., Ph.D

National Center for Global Health and Medicine
Disease Control and Prevention Center
Director

Dr. Norio Omagari graduated from Saga Medical School’s Faculty of Medicine, Saga University in 1997.
In the same year, he joined St. Luke’s International Hospital as a resident and then became a general internal medicine staff member. Thereafter, he joined Aida Memorial Hospital in 2001 and the Division of Infectious Diseases at the University of Texas-Houston Medical School in 2002. From 2004 to 2010, he assumed the posts of Senior Staff and Chief in the Division of Infectious Diseases at Shizuoka Cancer Center.
He joined the National Center for Global Health and Medicine and has been the center’s Director since 2012.
In

LATEST NEWS

Nanotis, the UTokyo-linked start-up, raises ¥45M from Shizuoka Capital, Hamamatsu Photonics, and individual investors

Press Release Nanotis (Head Office: Shibuya, Tokyo; CEO, Founder: Lisa Sakashita), the University of Tokyo-related start-up that is developing rapid diagnostic devices for infectious diseases, has raised ¥45,000,000 JPY (~$400,000 USD) from Shizuoka Capital (Head Office: Shizuoka, Shizuoka; President: Akira Hiruma), Hamamatsu Photonics (Head Office: Hamamatsu, Shizuoka; President: Akira Hiruma), […]

DBJ Women Entrepreneurs Prize, 6th DBJ New Business Plan Competition for Women Entrepreneurs

第6回DBJ女性新ビジネスプランコンペティションにて、DBJ女性起業優秀賞を受賞しました DBJ女性新ビジネスプランコンペティションは、日本政策投資銀行(DBJ)が執り行う、「革新性や事業性に優れ、発展可能性の高い新ビジネスを対象に行われる、ビジネスプランコンペティション」です。 詳細は日本政策投資銀行のプレスリリースをご覧ください。         2 3 4 5 7

Grand Prize, Bayer Innovation Connetion 2016

バイエル イノベーション コネクション 2016第 2 回 Grants4Apps Tokyoにて、大賞を受賞しました Grants4Apps Tokyo 2016は、革新的なデジタルヘルステクノロジーを支援するバイエル薬品のオープンイノベーションプログラムです。今回は「ベターライフのための革新的なモニタリングソリューション」をテーマに開催され、ナノティス株式会社の提案したインフルエンザ迅速検診システムが大賞を受賞しました。 詳細はバイエル社のプレスリリースをご覧ください。           1 2 3 4 5

 Information 

10/15/2018

Nanotis raises ¥45M from Shizuoka Capital, Hamamatsu Photonics, and individual investors.  See more

 Information 

04/01/2018

Commenced a joint research project with Yoshida-Akimoto Laboratory of the Department of Materials Engineering, Graduate School of Engineering, University of Tokyo.

 Information 

02/01/2018

Commenced a joint research project with the Synthetic Cell Engineering Lab of the Department of Bioengineering, Graduate School of Engineering, University of Tokyo.

 Information 

01/01/2018

Our corporate advisor Koji Nakao was appointed as the External Director of Nanotis.

 Press 

11/16/2017

Our CEO, Lisa Sakashita received the DBJ Outstanding Woman Entrepreneur Award at the "6th Woman Entrepreneurs New Business Plan Competition" hosted by Development Bank of Japan (DBJ). See more

 Information 

10/01/2017

Commenced a joint preclinical research project with the Disease Control and Prevention Center of the National Center for Global Health and Medicine.

 Information 

06/12/2017

Adopted for the 4th ASAC program, an acceleration program provided by the Tokyo Metropolitan Government and Deloitte Tomatsu Venture Support.

 Press 

04/26/2017

Reported in the April 26 issue of The Japan Times.

 Press 

02/13/2017

Reported in the February 18 issue of Weekly Toyo Keizai.

 Information 

02/07/2017

Koji Nakao, the current Corporate Advisor of Terumo Corporation and Chairman of the Japan Federation of Medical Devices Associations, was appointed as a corporate advisor of Nanotis.

 Information 

02/01/2017

Commenced a joint research project with Nagamune Laboratory of the Department of Chemistry & Biotechnology, Graduate School of Engineering, University of Tokyo.

 Press 

12/29/2016

Reported in the February issue of Monthly PROJECT DESIGN.

 Press 

12/07/2016

Reported in Nikkei Digital Health.

 Event 

12/05/2016

Received a grand prize at Grants4Apps Tokyo, an open innovation program hosted by Bayer Yakuhin. See more

 Information 

09/01/2016

Commenced a joint research project with the Fujita Laboratory of the Institute of Industrial Science, University of Tokyo. (The project ended in August 2017 due to the retirement of Professor Fujita.)

 Information 

06/06/2016

Founded.


CONTACT

Your Name*

E-Mail*

Title*

Message*


Acceptance